News
A new version of the McDonald criteria — the official guidelines used to diagnose MS — aim to make MS diagnosis faster and ...
An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...
Columnist Desiree Lama struggles to effectively manage stress, but given her multiple sclerosis, learning to do so is vital, ...
Columnist Ben Hofmeister worries about his MS cognitive symptoms worsening and wonders if he'll even be aware of the changes.
Fasting and ketogenic diets were found to benefit blood fats, weight, and blood pressure in MS, but did not reduce brain ...
Children who go on to develop pediatric-onset MS have more emergency department visits than their peers, starting years ...
Understanding how MS can impact your income, insurance, disability benefits, and budgeting allows you to plan ahead with ...
Paramagnetic rim lesions, or areas of damage in the brain and spinal cord, could be a useful tool for diagnosing MS, a study ...
The patent comes months after Immunic Therapeutics announced CALLIPER study results, which tested vidofludimus calcium in ...
TG Therapeutics has started enrolling adults with relapsing forms of MS for a Phase 3 trial testing a subcutaneous ...
A generic formulation of Zeposia will be manufactured and supplied by Netherlands-based Synthon, upon final approval by the ...
The Multiple Sclerosis Disease Activity test, which measures proteins to assess disease activity, has been available in the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results